Implementation of Genomics in Substance Use Disorder Treatment
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
Cigarette smoking remains one of the leading causes of preventable death. Effective smoking cessation medications exist but use of these treatments is low, making it difficult for most to quit smoking. Behavioral interventions are needed to engage current smokers in the process of quitting smoking and promote the use of evidence-based cessation medications.
At the same time, genetics influences one's smoking behaviors (e.g., how much they smoke, difficulty quitting) and risk of smoking-related diseases, yet these personalized factors have not been included in existing behavioral interventions. Incorporating these individualized factors into smoking cessation interventions may make them more personally engaging and thus motivating for treatment.
This study will pilot test a risk communication tool that is personalized to one's genetics and will demonstrate the feasibility of a larger trial to test the effect of this personalized genetically-informed intervention on smoking cessation.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- At least 18 years of age
- Smoked combustible cigarettes in past 30 days
- Computer access for remote-based study visits
Exclusion criteria
- Younger than 18 years of age
- No computer access
Trial design
Primary purpose
Allocation
Interventional model
Masking
148 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal